A gene expression signature identifying transient DNMT1 depletion as a causal factor of cancer-germline gene activation in melanoma.
BACKGROUND
Many human tumors show aberrant activation of a group of germline-specific genes, termed cancer-germline (CG) genes, several of which appear to exert oncogenic functions. Although activation of CG genes in tumors has been linked to promoter DNA demethylation, the mechanisms underlying this epigenetic alteration remain unclear. Two main processes have been proposed: awaking of a gametogenic program directing demethylation of target DNA sequences via specific regulators, or general deficiency of DNA methylation activities resulting from mis-targeting or down-regulation of the DNMT1 methyltransferase.


RESULTS
By the analysis of transcriptomic data, we searched to identify gene expression changes associated with CG gene activation in melanoma cells. We found no evidence linking CG gene activation with differential expression of gametogenic regulators. Instead, CG gene activation correlated with decreased expression of a set of mitosis/division-related genes (ICCG genes). Interestingly, a similar gene expression signature was previously associated with depletion of DNMT1. Consistently, analysis of a large set of melanoma tissues revealed that DNMT1 expression levels were often lower in samples showing activation of multiple CG genes. Moreover, by using immortalized melanocytes and fibroblasts carrying an inducible anti-DNMT1 small hairpin RNA (shRNA), we demonstrate that transient depletion of DNMT1 can lead to long-term activation of CG genes and repression of ICCG genes at the same time. For one of the ICCG genes (CDCA7L), we found that its down-regulation in melanoma cells was associated with deposition of repressive chromatin marks, including H3K27me3.


CONCLUSIONS
Together, our observations point towards transient DNMT1 depletion as a causal factor of CG gene activation in vivo in melanoma.
Group of Genetics and Epigenetics, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
Julie
J
Cannuyer
Group of Genetics and Epigenetics, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
Aurélie
A
Van Tongelen
Group of Genetics and Epigenetics, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
Axelle
A
Loriot
Group of Genetics and Epigenetics, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
Charles
C
De Smet